- Home
- OCFT vs RGLS Comparison
OCFT vs RGLS Comparison
Compare OCFT & RGLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCFT
- RGLS
- Stock Information
- Founded
- OCFT 2015
- RGLS 2007
- Country
- OCFT China
- RGLS United States
- Employees
- OCFT N/A
- RGLS N/A
- Industry
- OCFT Computer Software: Programming Data Processing
- RGLS Biotechnology: Pharmaceutical Preparations
- Sector
- OCFT Technology
- RGLS Health Care
- Exchange
- OCFT Nasdaq
- RGLS Nasdaq
- Market Cap
- OCFT 102.5M
- RGLS 102.1M
- IPO Year
- OCFT 2019
- RGLS 2012
- Fundamental
- Price
- OCFT $2.31
- RGLS $1.47
- Analyst Decision
- OCFT Strong Buy
- RGLS Strong Buy
- Analyst Count
- OCFT 1
- RGLS 6
- Target Price
- OCFT $7.00
- RGLS $10.33
- AVG Volume (30 Days)
- OCFT 44.0K
- RGLS 500.1K
- Earning Date
- OCFT 11-14-2024
- RGLS 11-07-2024
- Dividend Yield
- OCFT N/A
- RGLS N/A
- EPS Growth
- OCFT N/A
- RGLS N/A
- EPS
- OCFT 0.00
- RGLS N/A
- Revenue
- OCFT $407,825,504.00
- RGLS N/A
- Revenue This Year
- OCFT N/A
- RGLS N/A
- Revenue Next Year
- OCFT N/A
- RGLS N/A
- P/E Ratio
- OCFT $24.34
- RGLS N/A
- Revenue Growth
- OCFT N/A
- RGLS N/A
- 52 Week Low
- OCFT $0.87
- RGLS $1.08
- 52 Week High
- OCFT $4.98
- RGLS $3.79
- Technical
- Relative Strength Index (RSI)
- OCFT 47.34
- RGLS 48.95
- Support Level
- OCFT $2.10
- RGLS $1.30
- Resistance Level
- OCFT $2.52
- RGLS $1.65
- Average True Range (ATR)
- OCFT 0.25
- RGLS 0.10
- MACD
- OCFT -0.05
- RGLS -0.00
- Stochastic Oscillator
- OCFT 23.44
- RGLS 48.57
About OCFT OneConnect Financial Technology Co. Ltd.
OneConnect Financial Technology Co Ltd is a provider of technology platforms. Its platform provides cloud-native technology solutions that integrate financial services with market technology. The company offers technology applications and technology-enabled business services to financial institutions in China. Its technology solutions cover multiple verticals in the financial services industry, including banking, insurance and asset management, across the full scope of their businesses from sales and marketing and risk management to customer services and operations, as well as technology infrastructures such as data management and cloud services. The firm operates in two segments namely Technology Solutions which is the key revenue driver and Virtual Bank Business.
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.